|Videos|December 16, 2020
A Labeling Indication of SPMS Can Treat More Patients
Fred Lublin, MD, says a new labeling indication of Secondary Progressive Multiple Sclerosis broadens whom you can treat. He adds this will be very helpful to patients because it will treat groups that are progressing slowly without agents of activity.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
3 things to know about CVS Health’s 2025 earnings
3
A conversation about the consequences of Florida’s HIV medication cuts with Colleen Kelley, M.D., M.P.H., immediate past chair of the HIVMA and HIV specialist in Atlanta, Georgia
4
IRA price reductions to have little impact on future innovation, analysis finds
5





















